The Career Development Award has been given annually to young investigators to pursue research, which complements the disciplines emphasized by the Duke SPORE. Our first recipient was Dr. Andrew Futreal who was recruited to Duke to help us build a program in breast cancer genetics. Dr. Futreal and his collaborators succeeded in identifying BRCA2 during his tenure as the Career Award recipient and he used the resources made possible by the SPORE to make several important discoveries during our first year. In the second year, we supported Dr. Fan Fuan who represents an entirely different discipline. Dr. Yuan was recruited to Duke in the School of Engineering. He works on quantitative approaches to study drug distribution and pharmacology. He is interested in angiogenesis, vascular and tissue permeability and drug delivery. During his first year at Duke, he published several important studies and collaborated with several investigators in the SPORE. Rather than uses a cumbersome and inefficient system to recruit and select Award recipients, we have proposed a streamlined system of open nominations and selection by the Executive Committee. This year (year 3) we will support a cancer molecular biologist who has worked as a junior faculty member within the genetic testing core resource of the SPORE and designed our system of mutation screening BRCA1 and BRCA2. In years four and five, we propose to reduce the support offered to $25,000 per year to the legatee. This reduction is justified for the last two years, covered by this application for supplemental funding, in several ways: 1.) Resources are needed to finish the research started by major Projects within the SPORE and covered by a reduced budget, 2.) The competitive renewal process will begin in year four and 3.) We have supported six young faculty during the past three years using the SPORE and Planning Grant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA068438-04
Application #
6103141
Study Section
Project Start
1998-09-01
Project End
1999-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Osada, Takuya; Hartman, Zachary C; Wei, Junping et al. (2018) Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers. Breast Cancer Res 20:90
Goncalves, Rodrigo; DeSchryver, Katherine; Ma, Cynthia et al. (2017) Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer. Breast Cancer Res Treat 165:355-364
Mertins, Philipp; Yang, Feng; Liu, Tao et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13:1690-704
Li, Shunqiang; Shen, Dong; Shao, Jieya et al. (2013) Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep 4:1116-30
Cao, Yiting; Eble, Joseph M; Moon, Ejung et al. (2013) Tumor cells upregulate normoxic HIF-1? in response to doxorubicin. Cancer Res 73:6230-42
Ellis, Matthew J; Ding, Li; Shen, Dong et al. (2012) Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486:353-60
D'Amato, Nicholas C; Ostrander, Julie H; Bowie, Michelle L et al. (2012) Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. PLoS One 7:e45684
Aird, Katherine M; Allensworth, Jennifer L; Batinic-Haberle, Ines et al. (2012) ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells. Breast Cancer Res Treat 132:109-19
Il'yasova, Dora; Kennedy, Kelly; Spasojevic, Ivan et al. (2011) Individual responses to chemotherapy-induced oxidative stress. Breast Cancer Res Treat 125:583-9
Ye, Xiaodong; Fels, Diane; Tovmasyan, Artak et al. (2011) Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate. Free Radic Res 45:1289-306

Showing the most recent 10 out of 103 publications